Status:
COMPLETED
International Liver Surgery Outcomes Study
Lead Sponsor:
Royal Free Hospital NHS Foundation Trust
Collaborating Sponsors:
Hospital Miguel Servet
Conditions:
Liver Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study was to designed to measure the true worldwide practice of liver surgery and associated outcomes by recruiting multiple international centres, committing to consecutive patient registration ...
Detailed Description
Liver surgery was associated with at least 10% mortality in the 1970's. The safety of liver surgery has dramatically improved since with a mortality of now around 1-2%. Individual centres postulate th...
Eligibility Criteria
Inclusion
- All indications (including benign and living donor resections)
- All co-morbidities
- Open, laparoscopic or robotic
- Single wedge resections to extended liver resections
- Single or two-stage hepatectomies
- Procedures with liver volume enhancement such as PVE, PVL, ALPPS.
- Resections involving cold perfusion (ex-situ and ante-situ)
- There are no exclusion criteria as related to indication, age or comorbidities.
Exclusion
- Liver transplantation
- Imaging-guided liver ablation techniques alone
- Liver biopsies
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT03768141
Start Date
January 1 2019
End Date
March 31 2020
Last Update
November 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Zaragoza, Spain
Zaragoza, Spain, 50009
2
Royal Free Hospital
London, United Kingdom, NW3 2QG